Mutational load of the mitochondrial genome predicts pathological features and biochemical recurrence in prostate cancer.
about
Mitochondrial genome variation and prostate cancer: a review of the mutational landscape and application to clinical management.Low circulating levels of the mitochondrial-peptide hormone SHLP2: novel biomarker for prostate cancer risk.Altered mitochondrial genome content signals worse pathology and prognosis in prostate cancer.
P2860
Mutational load of the mitochondrial genome predicts pathological features and biochemical recurrence in prostate cancer.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 05 October 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Mutational load of the mitocho ...... recurrence in prostate cancer.
@en
Mutational load of the mitocho ...... recurrence in prostate cancer.
@nl
type
label
Mutational load of the mitocho ...... recurrence in prostate cancer.
@en
Mutational load of the mitocho ...... recurrence in prostate cancer.
@nl
prefLabel
Mutational load of the mitocho ...... recurrence in prostate cancer.
@en
Mutational load of the mitocho ...... recurrence in prostate cancer.
@nl
P2093
P2860
P50
P356
P1433
P1476
Mutational load of the mitocho ...... recurrence in prostate cancer.
@en
P2093
Anne-Maree Haynes
Desiree C Petersen
Judith Grogan
Ruth J Lyons
Vanessa M Hayes
P2860
P304
P356
10.18632/AGING.101044
P50
P577
2016-10-05T00:00:00Z